全域智慧就业资讯服务平台
全国
全国
安徽
北京
重庆
福建
甘肃
广东
广西
贵州
海南
河北
河南
黑龙江
湖北
湖南
吉林
江苏
江西
辽宁
内蒙古
宁夏
青海
山东
山西
陕西
上海
四川
天津
西藏
新疆
云南
浙江
香港
澳门
台湾
400-633-0111
硕博招聘 > 海外博士招聘 > 荷兰乌得勒支大学2024年招聘博士后(EV介导的 CRISPR-Cas9递送)

荷兰乌得勒支大学2024年招聘博士后(EV介导的 CRISPR-Cas9递送)

2024-05-29 10:15:57
博士研究生招聘网
分享:

荷兰乌得勒支大学2024年招聘博士后(EV介导的 CRISPR-Cas9递送)

乌得勒支大学(Utrecht University,简称:UU),又名乌特勒支大学,是一所公立研究型大学,欧洲最古老的大学之一,多次被U.S. News和软科世界大学学术排名评为荷兰第一。

乌得勒支大学建立于1636年,该校位于荷兰第四大城市乌得勒支。迄今为止,乌得勒支大学共培养出12位诺贝尔奖得主以及15位斯宾诺莎奖得主。学校现为欧洲研究型大学联盟和世界大学联盟等组织成员。

Postdoc on EV-mediated CRISPR-Cas9 Delivery

Utrecht University - Faculty of Science

Utrecht, Netherlands

Your job

Over the last decade, CRISPR/Cas9-based techniques have been developed for various genomic engineering strategies in eukaryotic cells. Using single guide RNAs (sgRNA) containing specific targeting sequences, Cas9 can target precise genomic locations. Thus, CRISPR/Cas9-based techniques are of substantial interest for the development of novel therapies to treat genetic diseases. Moreover, as they can be targeted to precise genomic targets with high specificity, they have considerable therapeutic potential for currently “un-druggable” pathologies. Unfortunately, one of the major hurdles in the development of CRISPR/Cas9-based therapies is the intracellular delivery of Cas9-sgRNA complexes. Cas9-sgRNA complexes are unable to cross the cell membrane due to their large size, as well as their negative charge. Moreover, Cas9-sgRNA complexes need to be shielded from opsonization and degradation in circulation, do to their immunogenicity. Your project will focus on the development of extracellular vesicle (EV)-mediated strategies for CRISPR/Cas9 delivery to address these challenges.

Under the combined supervision of Dr Olivier de Jong (UU) and Dr Pieter Vader (UMCU) you will develop and optimise extracellular vesicle-mediated loading and delivery strategies of CRISPR-Cas9 ribonucleoprotein (RNP) complexes and DNA templates and study the uptake pathways and kinetics in target cells. As a functional readout, the engineered EVs will be studied for their efficiency in genomic engineering based on homology-independent targeted insertion (HITI) and homology-directed repair (HDR) pathways. You will design and test fusion proteins through conventional cloning techniques in DNA plasmids. These fusion proteins will consist of EV-enriched proteins, Cas9, and previously confirmed cleavable linker sequences. These plasmids will then be transfected into EV-producing cells to test their efficacy in Cas9 loading and delivery. Initial DNA templates will encode fluorescent (eGFP) reporter genes and will be tested on various cell lines. If successful, DNA sequences of CAR-T cell receptors will be loaded into EVs and delivered to various relevant cell types, including Jurkat cells and PBMC-derived T-cells. To gain a better understanding of the cellular processes that play a role in EV-mediated cargo delivery, cellular uptake, intracellular trafficking, and delivery will be studied using confocal microscopy. Experimental work will be performed at the department of Pharmaceutics at Utrecht University, as well as at the CDL Research department at the University Medical Center.

This project is funded by the Eurostars funding programme, and this postdoctoral research position will be part of a collaboration between various academic partners (Utrecht University, dept. of Pharmaceutics; University Medical Center Utrecht, CDL Research dept.) and industrial partners (ExoVectory and EVerZom). The goal of this consortium is to combine the expertise and technologies of the consortium members to develop novel strategies for EV-mediated delivery and genomic integration of DNA sequences using CRISPR-Cas9. These expertises consist of EV-mediated Cas9 delivery (UU), EV uptake and trafficking (UMCU), DNA loading and delivery (ExoVectory), and up- and downstream processing for scalable EV production (EVerZom), respectively.

Your qualities

We are looking for a candidate who meets (several of) the following requirements:

a PhD in the field of Biology, Biomedical Sciences, Pharmaceutical Sciences, or related fields (or close to graduation);

a background in at least one of the following areas: CRISPR-Cas, extracellular vesicles, cell biology, cloning/protein engineering, or virology;

preferably experience with cell culture and analysis (e.g. Western Blot, Microscopy, Flow Cytometry, and/or qPCR);

excellent communicative skills in English, both in writing and speech;

excited to collaborate with both academic and industrial research partners.

应聘时请将简历抄送一份到:jiuyeqiao@eol.cn,邮件标题:应聘单位名称、姓名
更多资讯!欢迎扫描下方二维码关注就业桥(微信号:就业桥)。
关键词阅读
荷兰乌得勒支大学
2024年招聘博士后
最新职位 更多
相关栏目
院校硕士招聘 更多>
企业硕士招聘 更多>
科研院所硕士招聘 更多>
医疗卫生硕士招聘 更多>
博士招聘 更多>
收起

意见收集

关闭

您对就业桥有任何建议意见都可以给我们留言哦~

取消
确定